IT Leaders Say Employees Not Fully Prepared for Cyberattacks
Research by Egress Shows Human Activated Risks Comprise the Top Three Threats for Organisations London,…
Research by Egress Shows Human Activated Risks Comprise the Top Three Threats for Organisations London,…
Orphazyme A/S in restructuringCompany announcementNo. 18/2022www.orphazyme.comCompany Registration No. 32266355 NOTICE TO HOLDERS OF AMERICAN DEPOSITARY…
CAMBRIDGE, Mass., April 06, 2022 (GLOBE NEWSWIRE) — Evelo Biosciences, Inc. (Nasdaq:EVLO), a clinical stage…
Vancouver, British Columbia–(Newsfile Corp. – April 6, 2022) – Moovly Media Inc. (TSXV: MVY) (OTCQB:…
Lynk to provide commercial satellite-direct-to-phone service this year FALLS CHURCH, Va.–(BUSINESS WIRE)–Lynk Global, Inc. (Lynk),…
CX Effect will leverage disruptive AI technology from Dialpad to enhance productivity and communication SAN…
SAN RAMON, Calif. & SINGAPORE–(BUSINESS WIRE)–Chevron (NYSE: CVX) announced an agreement to join the Global…
Together, the two companies are at the forefront of communication service providers’ 5G business transformation…
ARC, Inc. joins AWS’s Public Sector Partner Program to help shape the future of ground…
Carvana Grows Maine Presence With As-Soon-As-Next-Day Delivery BANGOR, Maine–(BUSINESS WIRE)–Carvana (NYSE: CVNA), the leading e-commerce…
NEW YORK–(BUSINESS WIRE)–Signature Bank (Nasdaq: SBNY), a New York-based, full-service commercial bank, announced today new…
DENVER–(BUSINESS WIRE)–Advanced Energy (Nasdaq: AEIS) – a global leader in highly engineered, precision power conversion,…
LONDON – 06 APRIL, 2022 – Paysend, the UK-based fintech with over 6.5 million customers,…
Paris/San Francisco – Wednesday 6th April 2022 – Platform.sh, a unified, secure, enterprise-grade platform for…
Guerbet strengthens its Executive Committee with the appointment of Charlotte Bamière, General Counsel Villepinte,…
Regeneron receives access to ViGeneron’s vgAAV capsids for one inherited retinal disease target and an…
LIfT BioSciences N-LIfT cell therapy shows complete and superior cell killing in solid tumour organoids…
Company announcement no. 03/2022 April 6, 2022 Strong Q2 growth in a challenging environment Statement…
MAINTAINING HIGH LEVEL RESULTS IN 2021 Total turnover of €184.7m Growth in non-COVID activities (+14%)…
Extending existing master services agreement with Ares Genetics, to develop digital platform for development and…